impact factor
logo
 

Letters to the Editor

 

Macrophage activation syndrome after BNT162b2 mRNA vaccination successfully treated with corticosteroids


1, 2, 3, 4, 5, 6

 

  1. Infection Control and Education Center, and Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
  2. Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, and Department of Infectious Diseases, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan. takahiro-takazono@nagasaki-u.ac.jp
  3. Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  4. Department of Respiratory Medicine, Nagasaki University Hospital, Nagasaki, Japan.
  5. Department of Immunology and Rheumatology, Division of Advanced Preventive Medical Sciences, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.
  6. Department of Respiratory Medicine, Nagasaki University Hospital, and Department of Respiratory Medicine, Nagasaki University Graduate School of Biomedical Sciences, Nagasaki, Japan.

CER15130
2022 Vol.40, N°5
PI 1060
Letters to the Editor

Free to view
(click on article PDF icon to read the article)

PMID: 35084316 [PubMed]

Received: 02/09/2021
Accepted : 08/11/2021
In Press: 05/01/2022
Published: 13/05/2022

Rheumatology Article